Gel4Med

Boston, United States Founded: 2015 • Age: 11 yrs
Gel4Med is focused on developing bioinspired medical solutions.

About Gel4Med

Gel4Med is a Healthcare company based in Boston (United States) founded in 2015. Gel4Med is focused on developing bioinspired medical solutions. It operates on a HealthTech and Direct-to-Consumer (D2C) model. The company has 9 employees. Gel4Med offers products and services including G4Derm™ Plus, G4Derm™, and Smart Materials Platform™. Its focus areas include Medical Devices and Wound Care. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.

Company details

Gel4Med is engaged in the development of advanced medical solutions through bioinspiration and materials engineering. The company is based on its proprietary Smart Materials Platform technology, which is utilized to address unmet clinical needs in wound care and surgical reconstruction. Products such as G4Derm and G4Derm Plus have been cleared by the FDA for market use. Collaborations with institutions like the University of Miami for spinal cord injury treatments are also pursued. The company operates within the healthcare sector, focusing on innovative biomaterials to improve patient outcomes.

  • Headquarters Boston, United States
  • Employees 9
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website gelformed.com
  • Social LinkedIn X
  • Legal Name Gel4med
Key Metrics
  • Latest Funding Round
    $2.65M (USD), Grant

    Sep 2023

  • Investors
    HHS

    & 3 more

  • Employee Count
    9

Products & Services of Gel4Med

Gel4Med offers a comprehensive portfolio of products and services, including G4Derm™ Plus, G4Derm™, and Smart Materials Platform™.

G4Derm™ Plus
Medical Device

A flowable biomimetic matrix for managing complex wounds.

G4Derm™
Medical Device

A biosynthetic matrix for wound care and reconstruction.

Smart Materials Platform™
Technology Platform

A bioengineering platform for developing therapeutics and devices.

Funding Insights of Gel4Med

  • Total Rounds 11
  • Last Round Grant — $2.65M
  • First Round $9,000

    (Apr 2015)

  • Investors Count 4

Latest 10 of 11 funding rounds of Gel4Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2023$2.65MGrant––
Aug 2020$300,000Grant––
Jul 2020$409,704Grant––
Apr 2019$4.28MGrant––
Feb 2019$225,000Grant––
Sep 2017$292,475Grant––
Sep 2017$298,530Grant––
Apr 2017Grant––
Apr 2017$223,866Grant––
May 2016$223,369Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Gel4Med

Gel4Med has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, UMass Lowell and America’s Seed Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Early-stage science-driven companies are supported through venture capital investments.
breakoutlabs.org
Undergraduate and graduate education programs are provided across disciplines.
1894uml.eduUnited States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Gel4Med

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Gel4Med

1 people are tracked at Gel4Med (1 in leadership); the tracked headcount is 9.

NameRoleGroup
Manav Mehta
Chief Executive OfficerLeadership
Premium access

Complete people profiles for Gel4Med

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Gel4Med

3 dated milestones of Gel4Med across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Gel4Med is founded.
  2. Funding First funding round of $9K.
  3. Funding Latest funding round, Grant, of $2.6M.

Competitors of Gel4Med

Gel4Med has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
Premium access

Detailed competitors of Gel4Med

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Gel4Med (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gel4med

Premium access

Complete news archive for Gel4Med

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gel4Med

Gel4Med was founded in 2015.

Gel4Med is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Gel4Med has 9 employees.

Gel4Med is engaged in the development of advanced medical solutions through bioinspiration and materials engineering. The company is based on its proprietary Smart Materials Platform technology, which is utilized to address unmet clinical needs in wound care and surgical reconstruction. Products such as G4Derm and G4Derm Plus have been cleared by the FDA for market use. Collaborations with institutions like the University of Miami for spinal cord injury treatments are also pursued. The company operates within the healthcare sector, focusing on innovative biomaterials to improve patient outcomes.

Gel4Med's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.

Gel4Med offers G4Derm™ Plus, G4Derm™, and Smart Materials Platform™.

Gel4Med has 4 investors. Key investors include HHS, UMass Lowell, America’s Seed Fund, and Breakout Ventures.

Gel4Med operates through Gel4med.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available